Dog Pemphigus: Autoimmune Skin Disease and Welfare Management

Pemphigus is a family of autoimmune skin diseases in dogs that cause painful blistering and crusting of the skin and mucous membranes, requiring long-term immunosuppressive management with significant welfare implications.

Key Facts

Pemphigus foliaceus is the most common autoimmune skin disease in dogs, causing crusting and scaling particularly on the face, ears, and foot pads
Pemphigus vulgaris is less common but more severe, causing painful ulceration of mucous membranes and the skin
The diseases result from autoantibodies attacking the proteins that bind skin cells together
Chow Chows, Akitas, Doberman Pinschers, and Finnish Spitz have higher breed predisposition
Treatment requires immunosuppressive drugs including glucocorticoids, azathioprine, or mycophenolate mofetil
Drug side effects — including increased thirst, urination, weight gain, and immunosuppression — create secondary welfare concerns
Most dogs require lifelong medication with careful dose management to balance disease control against drug side effects

Welfare Considerations

Pemphigus causes significant welfare compromise through both direct disease effects and treatment side effects. Active pemphigus foliaceus produces thick, painful crusts on pressure points, foot pads, and the face that crack and bleed with normal movement; pemphigus vulgaris ulcerates the mouth and body surfaces, causing severe pain that impairs eating and normal function. The immunosuppressive treatment required to control disease creates vulnerability to infections and requires regular monitoring for drug-related organ toxicity. Long-term glucocorticoid use causes its own welfare harms including muscle wasting, increased infection risk, and behavioural changes associated with steroid excess. The welfare goal in pemphigus management is to find the lowest effective drug dose that controls clinical signs while minimising treatment side effects — a balance that requires regular re-evaluation as disease activity fluctuates with seasons and stress.

What You Can Do

If your dog develops facial crusting, foot pad scaling, or oral ulceration, seek prompt dermatological assessment
Work with a veterinary dermatologist to establish the minimum effective immunosuppressive dose
Monitor for drug side effects at every veterinary visit and report changes in thirst, appetite, or behaviour
Protect immunosuppressed dogs from infection risks including contact with sick animals
Use a quality-of-life tracking tool to ensure your dog's overall wellbeing remains positive despite ongoing treatment